Literature DB >> 16507712

Evaluation of urothelial stretch-induced cyclooxygenase-2 expression in novel human cell culture and porcine in vivo ureteral obstruction models.

Travis J Jerde1, William S Mellon, Dale E Bjorling, Stephen Y Nakada.   

Abstract

Obstruction and stretch induce cyclooxygenase (COX)-2 expression and prostanoid synthesis in urinary tissues, causing pain, inflammation, hypercontractility, and cell proliferation. Our objective was to characterize acute COX-2 induction during in vivo ureteral obstruction, establish a cell culture model of urothelial stretch-induced COX-2 expression, and evaluate whether mechanotransduction could alter transcriptional and post-transcriptional regulation of COX-2. We performed laparoscopic unilateral ureteral ligation in pigs and allowed progression for 1, 2, 6, 24, or 48 h. We evaluated COX-2 expression with reverse transcriptase (RT)-polymerase chain reaction (PCR) and immunoblotting. We cultured primary human urothelial cells on stretch plates, applied stretch for up to 48 h, and measured COX-2 expression by RT-PCR and immunoblotting, transcription with run-on assays, and mRNA stability with actinomycin mRNA decay assays. In vivo ureteral obstruction induced COX-2 expression 4-fold within 6 h, maintaining induction for 24 h. In cell culture, stretch induced COX-2 steady-state mRNA and protein within the first 3 h of stretch, maintaining this induction for over 6 h. Three hours of stretch doubled COX-2 transcription relative to unstretched controls and increased COX-2 mRNA half-life 3-fold. This is the first report to characterize in vivo temporal stretch-induced COX-2 expression in the urothelium and establish a primary urothelial cell culture model for the study of stretch-induced COX-2 mechanisms. This is also the first report to identify alterations in steady-state COX-2 mRNA having components of both transcriptional and post-transcriptional regulation of stretch-regulated COX-2. Future elucidation of COX-2 signaling may identify novel therapeutic targets for treating stretch and distension of urinary tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507712     DOI: 10.1124/jpet.105.099184

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Acute bacterial inflammation of the mouse prostate.

Authors:  Bayli J Boehm; Sara A Colopy; Travis J Jerde; Christopher J Loftus; Wade Bushman
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

2.  Increased cyclooxygenase-2 expression and prostaglandin E2 production in pressurized renal medullary interstitial cells.

Authors:  Inge Carlsen; Kaitlin E Donohue; Anja M Jensen; Angela L Selzer; Jie Chen; Dix P Poppas; Diane Felsen; Jørgen Frøkiær; Rikke Nørregaard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-07-07       Impact factor: 3.619

3.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07

4.  Nicotine augments glomerular injury in a rat model of acute nephritis.

Authors:  Edgar A Jaimes; Run-Xia Tian; Mahesh S Joshi; Leopoldo Raij
Journal:  Am J Nephrol       Date:  2008-10-10       Impact factor: 3.754

Review 5.  Nicotine signaling and progression of chronic kidney disease in smokers.

Authors:  Gaurav Jain; Edgar A Jaimes
Journal:  Biochem Pharmacol       Date:  2013-07-26       Impact factor: 5.858

6.  Effects of a non-selective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo.

Authors:  V Chaignat; H Danuser; M H Stoffel; S Z'brun; U E Studer; M Mevissen
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

7.  Ureteral Access Sheath Influence on the Ureteral Wall Evaluated by Cyclooxygenase-2 and Tumor Necrosis Factor-α in a Porcine Model.

Authors:  Søren Kissow Lildal; Rikke Nørregaard; Kim Hovgaard Andreassen; Frederikke Eichner Christiansen; Helene Jung; Malene Roland Pedersen; Palle Jörn Sloth Osther
Journal:  J Endourol       Date:  2017-01-24       Impact factor: 2.942

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.